Home/Filings/4/0001562180-21-004343
4//SEC Filing

STARR KEVIN P 4

Accession 0001562180-21-004343

CIK 0001597553other

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 9:15 AM ET

Size

7.1 KB

Accession

0001562180-21-004343

Insider Transaction Report

Form 4
Period: 2021-06-16
STARR KEVIN P
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2021-06-16$56.05/sh+17,842$999,983320,659 total
Footnotes (1)
  • [F1]This transaction was executed in multiple trades at prices ranging from $56.0447 USD to $56.9527 USD. The price reported above reflects the weighted average purchase price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Issuer

Sage Therapeutics, Inc.

CIK 0001597553

Entity typeother

Related Parties

1
  • filerCIK 0001192603

Filing Metadata

Form type
4
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 9:15 AM ET
Size
7.1 KB